Marshall & Ilsley (M&I) Trust Company has signed a three-year licensing agreement for Xcitek’s CostBasis (XCB) software and will use it to process cost allocation factors and tax opinions on corporate actions. Mark Cashion, assistant vice president, M&I Trust Company, says the move to XCB has increased accuracy and timeliness of processing cost basis activity on corporate actions for customers.
A-Team Insight Blogs
Related content
WEBINAR
Upcoming Webinar: Entity identification and client lifecycle management – How financial institutions can drive $4 billion in cost savings
Date: 21 January 2021 Time: 10:00am ET / 3:00pm London / 4:00pm CET Duration: 50 minutes A new model in Legal Entity Identifier (LEI) issuance has created significant opportunities for financial institutions to capitalise on their KYC and AML due diligence. By becoming Validation Agents and obtaining LEIs on behalf of their clients, financial institutions...
BLOG
GLEIF Calls Global Industries to Join Development of Cryptographically Verifiable LEI
The Global Legal Entity Identifier Foundation (GLEIF) has set out grand plans to create a digitised LEI service based on a digitally verifiable credential containing the LEI – the vLEI – and able to provide automated identity verification between counterparties. The ambition is for all industry sectors globally, including financial services, to embed new and...
EVENT
Data Management Summit New York City
Now in its 10th year, the Data Management Summit (DMS) in NYC explores the shift to the new world where data is redefining the operating model and firms are seeking to unlock value via data transformation projects for enterprise gain and competitive edge.
GUIDE
Enterprise Data Management Europe 2010
he US may seem to be ahead of the rest of the world in terms of championing the data management cause with the inclusion of reference data focused items in the Dodd-Frank Act, but Europe is not too far behind. Senior European level officials such as European Central Bank (ECB) president Jean-Claude Trichet have taken...